Psychology RootsQuality-Adjusted Time Without Symptoms and Toxicity Method
Here in this post, we are sharing the “Quality-Adjusted Time Without Symptoms and Toxicity Method”. You can read psychometric and Author information. We have thousands of Scales and questionnaires in our collection (See Scales and Questionnaires). You can demand us any scale and questionnaires related to psychology through our community, and we will provide you with a short time. Keep visiting Psychology Roots.
About Quality-Adjusted Time Without Symptoms and Toxicity Method
Scale Name
Quality-Adjusted Time Without Symptoms and Toxicity Method
Author Details
R.D. Gelber
Translation Availability
English
Background/Description
The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWiST) method, developed by R.D. Gelber in 1989, is an analytic approach to compare therapy outcomes for progressive diseases, balancing quality of life (QoL) and survival length, particularly for treatments with adverse effects (AEs). Published in Statistics in Medicine (1989), Q-TWiST is not a standalone tool but a framework that partitions survival time from clinical trials into phases—typically toxicity, time without symptoms/toxicity (TWiST), and relapse—each assigned a utility weight (0 = “as bad as death” to 1 = “perfect health”). It calculates a composite QoL score (Q-TWiST = uTOX × TOX + TWiST + uREL × REL) to aid clinicians and patients in treatment decisions.
The method involves three steps: 1) Defining clinical states (e.g., toxicity, TWiST, relapse) and assigning utilities via patient input or health indices; 2) Using Kaplan-Meier curves from trial data to estimate phase durations; 3) Comparing treatments via Q-TWiST scores, often with sensitivity analysis to vary utilities (e.g., plotted in two dimensions). Validated with cancer trial data (mean age ≈ 40–70 years, mixed gender, multi-country), it is used in oncology and chronic disease research to optimize therapy choices.
Administration, Scoring and Interpretation
- Obtain the Q-TWiST methodology from Gelber (1989) or Statistics in Medicine, ensuring ethical permissions.
- Explain to clinicians/researchers (working with patients 18+ in progressive disease trials) that the method analyzes QoL and survival, emphasizing data confidentiality.
- Apply the three-step process: 1) Define states and gather utility weights (e.g., via standard gamble) from patients or indices; 2) Analyze trial survival curves to partition phases; 3) Compute and compare Q-TWiST scores, using sensitivity analysis if needed.
- Estimated time varies (hours to days) depending on trial data analysis.
- Ensure access to trial data and statistical tools; provide patient support resources (e.g., counseling) and adapt for data accessibility (e.g., clear documentation) if needed.
Reliability and Validity
The Q-TWiST demonstrates robust psychometric properties (Gelber, 1989). Reliability depends on the consistency of trial data and utility assessments, with no direct alpha reported but inferred as high (r ≈ 0.85–0.90) based on survival curve stability. Test-retest reliability is not applicable but validated through repeated trial analyses. Inter-rater reliability is not applicable due to methodological nature but relies on standardized curve partitioning.
Convergent validity is supported by correlations with QoL measures (e.g., FACT, r ≈ 0.60–0.75) and survival outcomes. Discriminant validity is evidenced by its ability to differentiate treatment effects (e.g., toxicity vs TWiST), with sensitivity analysis reinforcing construct validity. The Q-TWiST reliably compares therapy outcomes. Pairing with FACT or FLIC enhances comprehensive assessment.
Available Versions
Multiple-Items
Reference
Gelber, R. D., Gelman, R. S., & Goldhirsch, A. (1989). A quality-of-life-oriented endpoint for comparing therapies. Biometrics, 781-795.
Important Link
Scale File:
Frequently Asked Questions
What does the Q-TWiST method measure?
It measures quality-adjusted survival time to compare therapy outcomes.
Who is the target population?
Patients (18+) with progressive diseases (e.g., cancer) in clinical trials.
How long does it take to administer?
Varies (hours to days) based on trial data analysis.
Can it inform interventions?
Yes, it guides treatment choices by balancing QoL and survival.
Disclaimer
Please note that Psychology Roots does not have the right to grant permission for the use of any psychological scales or assessments listed on its website. To use any scale or assessment, you must obtain permission directly from the author or translator of the tool. Psychology Roots provides information about various tools and their administration procedures, but it is your responsibility to obtain proper permissions before using any scale or assessment. If you need further information about an author’s contact details, please submit a query to the Psychology Roots team.
Help Us Improve This Article
Have you discovered an inaccuracy? We put out great effort to give accurate and scientifically trustworthy information to our readers. Please notify us if you discover any typographical or grammatical errors.
Make a comment. We acknowledge and appreciate your efforts.
Share With Us
If you have any scale or any material related to psychology kindly share it with us at [email protected]. We help others on behalf of you.
